Register Login
Register to leave comments
  • News bot Oct. 3, 2025, 1:20 a.m.

    📋 Leap Therapeutics, Inc. (LPTX) - Financial Results

    Filing Date: 2022-08-12

    Accepted: 2022-08-12 07:11:25

    Event Type: Financial Results

    Event Details:

    Leap Therapeutics Inc (LPTX) Reports Q3 2022 Financial Results Leap Therapeutics Inc (LPTX) announced its financial results for the period ending Q3 2022. Key Financial Highlights:
    • Revenue: 375
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 90883
      • targeting the Dickkopf-1 (DKK1) protein. DKN-01 is in clinical trials in patients with esophagogastric, colorectal, and gynecologic cancers. Leap has entered into a strategic collaboration with BeiGene, Ltd. for the rights to develop DKN-01 in Asia (excluding Japan), Australia, and New Zealand. For more information about Leap Therapeutics, visit http://www.leaptx.com or view our public filings with the SEC that are available via EDGAR at http://www.sec.gov or via https://investors.leaptx.com/. FORWARD-LOOKING STATEMENTS This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2022 2021 Change ($) Change (%)
    Operating Expenses Loss From Operations 9.63K 27.53K $-17.91K -65.04%
    Operating Expenses Interest Income 1.00 44.00 $-43.00 -97.73%
    Operating Expenses Interest Expense 16.00 38.00 $-22.00 -57.89%
    Current Assets Prepaid Expenses Other Current Assets 428.00 769.00 $-341.00 -44.34%
    Current Assets Property Equipment Net 28.00 36.00 $-8.00 -22.22%
    Current Liabilities Accounts Payable 7.55K 4.19K $3.36K +80.31%
    Revenue 375.00 375.00 $0.00 +0.00%
    Loss from Operations 9.63K 27.53K $-17.91K -65.04%
    Interest Income 1.00 44.00 $-43.00 -97.73%
    Interest Expense 16.00 38.00 $-22.00 -57.89%
    Net Loss 9.53K 27.40K $-17.87K -65.23%
    Prepaid Expenses and Other Current Assets 769.00 769.00 $0.00 +0.00%
    Property and Equipment, Net 36.00 36.00 $0.00 +0.00%
    Accounts Payable 4.19K 4.19K $0.00 +0.00%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Leap Therapeutics Inc
    • CIK: 0001509745
    • Ticker Symbol: LPTX
    • Period End Date: 2022-08-11
    • Document Type: 8-K

Search

News categories